ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.100
+0.050 (1.24%)
At close: Mar 31, 2025, 4:00 PM
4.142
+0.042 (1.02%)
Pre-market: Apr 1, 2025, 4:05 AM EDT

ENDRA Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
7.635.526.66.025.58
Upgrade
Research & Development
3.1956.555.485.92
Upgrade
Operating Expenses
10.8210.5213.1611.511.5
Upgrade
Operating Income
-10.82-10.52-13.16-11.5-11.5
Upgrade
Interest Expense
-----0.23
Upgrade
Other Non Operating Income (Expenses)
-0.690.46-0.02-0.040.01
Upgrade
EBT Excluding Unusual Items
-11.51-10.06-13.18-11.54-11.73
Upgrade
Other Unusual Items
---0.31-
Upgrade
Pretax Income
-11.51-10.06-13.18-11.23-11.73
Upgrade
Net Income
-11.51-10.06-13.18-11.23-11.73
Upgrade
Preferred Dividends & Other Adjustments
---0.120.4
Upgrade
Net Income to Common
-11.51-10.06-13.18-11.35-12.12
Upgrade
Shares Outstanding (Basic)
0----
Upgrade
Shares Outstanding (Diluted)
0----
Upgrade
EPS (Basic)
-56.94----
Upgrade
EPS (Diluted)
-56.94----
Upgrade
Free Cash Flow
--9.58-12.97-11.17-10.82
Upgrade
EBITDA
-10.77-10.4-13.06-11.38-11.4
Upgrade
D&A For EBITDA
0.050.120.10.120.1
Upgrade
EBIT
-10.82-10.52-13.16-11.5-11.5
Upgrade
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q